Counselors in Canterbury, CT Accepting Medicare

4 Counselors found. Showing 1 - 4

Ms. Pamela A. Kerouack-warner, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 312 N Society Rd, Canterbury, CT 06331 Phone: 860-465-7926

Linda Beth Lovrien Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 Knollwood Dr, Suite 6, Canterbury, CT 06331 Phone: 860-377-5805

Mrs. Desiree Brooker Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 Knollwood Dr, Canterbury, CT 06331 Phone: 860-546-9511

Mrs. Susan Marie Brunelle, LPC INTERN Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 Knollwood Dr, Canterbury, CT 06331 Phone: 860-546-9511

News Archive

Consumption of B-GOS prebiotic has positive effect on gut microbiota, immune systems of elderly people

Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno, a unique trans-galactooligosaccharide, and the Department of Food and Nutritional Sciences, The University of Reading, UK, today announce the results of human research demonstrating the positive effects of an advanced prebiotic on the immune system of the elderly.

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

Unusual compounds in pitcher plant could prove effective against human fungal infections

The moment insects like flies, ants and beetles fall into a pitcher, the plant's enzymes are activated and begin dissolving their new meal, obtaining nutrients such as carbon and nitrogen which are difficult to extract from certain soils.

Blood research could improve treatment for injured soldiers on the battlefield

Blood research conducted by biomedical engineers from The University of Texas at San Antonio College of Engineering, in collaboration with the Blood Research Program of the U.S. Army Institute of Surgical Research, could change the way injured soldiers are treated on the battlefield.

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

Read more Medical News

› Verified 4 days ago